Table 5.
Symptoms and biological parameters associated with survival.
| Patients That Survived | |||||
|---|---|---|---|---|---|
| Mean (SD)/Median [Q1-Q3]/No. (%) | |||||
| Yes | No | p | Odds Ratio, IC | ||
| Age | 87 (11) | 89 (8) | <0.001 | 1.066 (1.037–1.096) | |
| Basal Barthel Index | 60 (50) | 35 (48) | <0.001 | 0.974 (0.966–0.982) | |
| Profund scale | 7 (6) | 9 (4) | <0.001 | 1.152 (1.094–1.214) | |
| Presence of symptoms | 295 (71.3%) | 169 (97.1%) | <0.001 | 1.509 (1.397–1.631) | |
| Fever | 150 (65%) | 312 (88%) | <0.001 | 2.012 (1.674–2.418) | |
| Cough | 104 (62.3%) | 358 (85.4%) | <0.001 | 2.257 (1.772–2.875) | |
| Dyspnea | 108 (53%) | 354 (92.4%) | <0.001 | 3.277 (2.706–3.969) | |
| Anorexia | 79 (61%) | 383 (84%) | <0.001 | 2.358 (1.758–3.163) | |
| Delirium | 50 (46.3%) | 413 (86.4%) | <0.001 | 4.367 (3.165–6.024) | |
| Global deterioration | 130 (57%) | 333 (93%) | <0.001 | 2.843 (2.398–3.372) | |
| Main biological parameters | |||||
| Lymphocytes (no./µL) | 1263.3 (162.3) | 1190 (712.3) | 0004 | 0.999 (0.998–1.000) | |
| CRP | 67.2 (53.7) | 103.5 (80) | <0.001 | 1.014 (1.010–1.019) | |
| Ferritin (ng/mL) | 456.4 (161.4) | 639 (413.5) | <0.001 | 1.001 (1.001–1.002) | |
| Leukocytes (no./µL) | 7968 (2309.5) | 9169.1 (4782.4) | 0.02 | 1.000 (1.000–1.000) | |
| Creatinine (mg/dL) | 1.3 (0.47) | 1.36 (1.1) | 0.028 | 1.311 (1.013–1.694) | |
| ASAT | 26.1 (7.8) | 40 (26.2) | <0.001 | 1.046 (1.029–1.064) | |
| ALAT | 21.2 (6.8) | 32.8 (26.2) | <0.001 | 1.047 (1.028–1.067) | |
| Creatinine kinase | 116.3 (70.4) | 159.5 (122) | <0.001 | 1.006 (1.003–1.008) | |
Note: ALAT = alanine aminotransferase; ASAT = aspartate aminotransferase; CRP = C-reactive protein; SD = standard deviation; and Q1–Q3 = Quartile 1–Quartile 3. Significance threshold was 0.05.